Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-28

Clinical Trial Update: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia [Phase 3]

View source ↗

Summary

A Phase 3 multicenter, randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of oral lixivaptan capsules in adults with euvolemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lixivaptan (lixivaptan)

Snippet

Sponsor: CardioKine Inc. | Conditions: Hyponatremia With Normal Extracellular Fluid Volume | Phase 3 | Status: COMPLETED